Financial News
Latest News about NVAX
Recent news which mentions NVAX
Should You Give Up on Novavax?
April 14, 2022
From Motley Fool
3 Biotech Stocks That Could Help Make You a Fortune
April 14, 2022
From Motley Fool
Novavax Stock Up on Swiss Approval of Nuvaxovid
April 13, 2022
From InvestorPlace
Here Are 2 Reasons Why Vaccine Stocks Might Cool Off Soon
April 13, 2022
From Motley Fool
Novavax Stock Is Slumping: Why Buy the Dip?
April 12, 2022
From InvestorPlace
Tickers
NVAX
From InvestorPlace
This Growth Stock Has Market-Beating Potential
April 10, 2022
From Motley Fool
These COVID Stocks Will Be Incredibly Profitable
April 09, 2022
From Motley Fool
3 Pharmaceutical Stocks With Awesome Futures
April 09, 2022
From Motley Fool
Why Novavax Stock Dropped 23.6% This Week
April 08, 2022
From Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 07, 2022
From Benzinga
Vaccine Makers Down on FDA Meeting, Novavax Most at Risk
April 07, 2022
Tickers
NVAX
From InvestorPlace
Dear Biotech Investors: Novavax’s Comparable Vaccine Matters
April 07, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
From InvestorPlace
Don’t Bet on New Highs for Novavax Stock
April 06, 2022
From InvestorPlace
From Motley Fool
4 Top Stock Trades for Wednesday: Dogecoin, NVDA, TLRY, NVAX
April 05, 2022
From InvestorPlace
What's Going On With Novavax Shares Today?
April 05, 2022
From Benzinga
Tickers
NVAX
From InvestorPlace
What to Make of Novavax’s Adolescent Covid-19 Vaccine Move
April 05, 2022
Tickers
NVAX
From InvestorPlace
Novavax’s First Canadian Shipments Are Boosting NVAX Stock
April 04, 2022
Tickers
NVAX
From InvestorPlace
10 Investor Questions About COVID-19, Answered
April 03, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
